Post Profile

Roche eye drug fails late-stage trial in blow to pipeline

ZURICH (Reuters) - A drug Roche had hoped would prevent loss of vision and become a big seller failed a late-stage trial, leading some analysts to say on Friday it now had no future.
read more


Related Posts

Novartis eye drug works with fewer injections than rivals

Health : Reuters: Health

ZURICH (Reuters) - A drug developed by Novartis to treat vision loss in people over 65 does not need to be injected as frequently as a rival medicine from Regeneron to be effective, clinical trials showed on Tuesday.

Poor test results for Roche cloud growth prospects

Health : Reuters: Health

ZURICH (Reuters) - A run of disappointing drug trials at Roche has left analysts suggesting the view from its new 41-storey office building in Basel has become more clouded, with little chance of management now upgrading its growth ...

Inotek to consider strategic options after eye drug fails another study

Health : Reuters: Health

(Reuters) - Inotek Pharmaceuticals Corp said on Friday it would evaluate its lead experimental drug and consider strategic options after the eye drug failed another trial.

Roche's Tecentriq fails trial in advanced bladder cancer

Health : Reuters: Health

ZURICH (Reuters) - Roche's Tecentriq drug has failed a late-stage trial in people with previously treated advanced bladder cancer, the Swiss drugmaker said on Wednesday.

Roche bid for Avastin follow-on suffers blow with trial failure

Health : Reuters: Health

ZURICH (Reuters) - Swiss drugmaker Roche's bid to follow its blockbuster cancer drug Avastin with a newer, better drug took a hit when it announced on Thursday that an investigational therapy had failed in a study against metastatic...


Copyright © 2016 Regator, LLC